Clinical trial
Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines
NCT00615992 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- Not reported
- Enrollment
- 754 (actual)
- Sites
- 73
Conditions
As the registry lists them; a condition with its own page is linked.